CARCINOMA, PANCREATIC DUCTAL
Clinical trials for CARCINOMA, PANCREATIC DUCTAL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, PANCREATIC DUCTAL trials appear
Sign up with your email to follow new studies for CARCINOMA, PANCREATIC DUCTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Genetic test aims to match pancreatic cancer patients with best chemo
Disease control Recruiting nowThis study is testing a personalized approach to choose the first chemotherapy for people with advanced pancreatic cancer that has spread. Doctors will analyze the genetic makeup of a patient's tumor biopsy to predict which of two standard chemotherapy combinations might work bet…
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: NA • Sponsor: Institut Curie • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
First human test for new pill targeting a common Cancer-Causing gene
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of a new oral medicine, PF-07934040. It is being tested alone and in combination with other cancer drugs in people with advanced lung, colorectal, or pancreatic cancer that has a specific genetic change cal…
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New hope for tough cancer: drug combo trial seeks to control advanced pancreatic disease
Disease control Recruiting nowThis study is testing whether adding an oral drug called relacorilant to two standard chemotherapy drugs can help control advanced pancreatic cancer that has spread. It will involve about 60 adults whose cancer has not yet been treated. The main goal is to see if this three-drug …
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New lab test aims to match cancer patients with the right drug faster
Knowledge-focused Recruiting nowThis study is testing a new laboratory method to see if it can predict which cancer treatments will work best for a patient. Researchers will take a sample of a patient's tumor cells from a fluid or tissue biopsy and test how the cells react to different drugs in the lab. The goa…
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Sponsor: Travera Inc • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:18 UTC